Andrew Hedin

Vice President

Andrew Hedin is a vice president in Bessemer’s Cambridge office where he focuses on investments in healthcare.

Prior to joining Bessemer in 2015, Andrew worked at F-Prime Capital, Fidelity’s healthcare-focused venture capital fund, as well as Leerink Partners.

He earned an MBA with honors from The Wharton School, where he majored in health care management and finance, as well as a degree in biological basis of behavior from the University of Pennsylvania.

Companies

AccuVein

AccuVein

AccuVein is a global leader in medical imaging solutions.

Artemis Health

Artemis Health

Artemis Health’s next-generation data optimization platform enables benefits teams to quantify the impact of their programs, justify new and better programs for their members, and drive their benefits strategy.

Bright Health

Bright Health

Bright Health is a consumer focused health plan offering simple and affordable health insurance.

Collective Medical

Collective Medical

Collective Medical empowers care teams to improve patient outcomes by closing the communication gaps that undermine patient care.

Docent Health

Docent Health

Docent Health helps health systems design and implement better, more human patient experiences.

Fractyl

Fractyl

Fractyl develops innovative medical device solutions for the treatment of chronic diseases.

Subtle Medical

Subtle Medical

Subtle Medical uses AI to redefine the standards for medical imaging, making it faster, safer, and smarter.

Groups

Groups

Groups helps people recover from opiate use through therapy and medication.

Nym

Nym

Nym is a NLU based autonomous medical coding technology that enables healthcare facilities to optimize their revenue cycle processes.

Qventus

Qventus

Qventus optimizes decisions in hospitals in real time to reduce costs, improve quality and experience.

TScan Therapeutics

TScan Therapeutics

TScan Therapeutics is harnessing novel T cell systems to extend the promise of immunotherapy

Atlas Picks